PM calls off vote on Brexit deal
Commons vote deferred to allow appeal to the European Union over the Irish backstop.
Learn more
- Spread Type Floating
- Long position overnight fee -0.0100%
- Short position overnight fee -0.0123%
- Overnight fee time 22:00 (UTC)
- Min traded quantity 1
Based in Martinsried, Germany, MorphoSys (MOR) is a pharmaceutical company committed to antibody development. All antibodies, created by MorphoSys, are composed of 100% protein.
The company’s most advanced technology, HuCAL, is designed to approach drug discovery in a smart new way. In total, MorphoSys has developed a portfolio of over 100 human antibodies built with such compounds as guselkumab, anetumab ravtansine, gantenerumab.
MorphoSys stock is quoted at Frankfurt Stock Exchange.
The company is featured in the TecDAX index. Stay tuned to the MOR stock price info with Capital.com.
How we make money?
Capital.com makes the majority of it’s money through the spread, the difference between the buy and sell price.
Trade shares with leverage
Shares are available to trade with up to 5:1 leverage. Start trading with as little as $100 to control a position of $500
Shares CFD’s
Trade 24/5 on a wide range of shares
Buy and sell shares to take advantage of rises and falls in price
Profit and loss control
You can easily define Stops and Limits to request positions to close at a specified price.
Set up price alerts to be informed of big moves.
You might be interested in
